Enanta Pharmaceuticals (ENTA) Long-Term Investments (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Long-Term Investments of $21.99 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 65.2% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Long-Term Investments (2012 - 2026) Analysis & Trends
At the end of FY2022 (ended Sep 30, 2022), Enanta Pharmaceuticals' Long-Term Investments came in at $29.29 million, down 73.0% from FY2021.
- Annual Long-Term Investments shows a five-year compound annual growth rate of -16.0% (FY2017 to FY2022).
- In prior fiscal years, Enanta Pharmaceuticals' Long-Term Investments was $108.42 million in FY2021 (+232.2%), $32.63 million in FY2020 (-49.8%), $65.01 million in FY2019 (+296.7%) and $16.39 million in FY2018 (-76.6%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Long-Term Investments since fiscal Q3 2023.
- The strongest year-over-year quarter for Long-Term Investments in the past five years was fiscal Q3 2024, with growth of 617.6%; the weakest was fiscal Q3 2023, with a decline of 85.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Enanta Pharmaceuticals | 383.80 Mn | -344.19 Mn | - | 21.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.99 Mn |
| Mar 31, 2026 | 63.24 Mn |
| Dec 31, 2025 | 56.06 Mn |
| Jun 30, 2024 | 42.51 Mn |
| Jun 30, 2023 | 5.92 Mn |
| Mar 31, 2023 | 15.04 Mn |
| Dec 31, 2022 | 26.94 Mn |
| Sep 30, 2022 | 29.29 Mn |
| Jun 30, 2022 | 39.43 Mn |
| Mar 31, 2022 | 42.22 Mn |
| Dec 31, 2021 | 88.67 Mn |
| Sep 30, 2021 | 108.42 Mn |
| Jun 30, 2021 | 115.71 Mn |
| Mar 31, 2021 | 24.49 Mn |
| Dec 31, 2020 | 18.46 Mn |
| Sep 30, 2020 | 32.63 Mn |
| Jun 30, 2020 | 65.40 Mn |
| Mar 31, 2020 | 80.10 Mn |
| Dec 31, 2019 | 40.94 Mn |
| Sep 30, 2019 | 65.01 Mn |
API Access
Enanta Pharmaceuticals Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();